A randomized controlled trial of a novel mixed monoamine reuptake inhibitor in adults with ADHD
Open Access
- 1 January 2008
- journal article
- Published by Springer Nature in Behavioral and Brain Functions
- Vol. 4 (1) , 24
Abstract
NS2359 is a potent reuptake blocker of noradrenalin, dopamine, and serotonin. The aim of the study was to investigate the efficacy, safety and cognitive function of NS2359 in adults with a DSM IV diagnosis of ADHD.Keywords
This publication has 31 references indexed in Scilit:
- Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localizationPsychopharmacology, 2005
- Diagnosis and evaluation of adults with attention-deficit/hyperactivity disorderPsychiatric Clinics of North America, 2004
- Nonstimulant treatment of adult attention-deficit/hyperactivity disorderPsychiatric Clinics of North America, 2004
- ADHD treatment across the life cycle.2004
- Atomoxetine in adults with ADHD: two randomized, placebo-controlled studiesBiological Psychiatry, 2003
- A review of the pharmacotherapy of adults with Attention-Deficit/ Hyperactivity DisorderJournal of Attention Disorders, 2001
- Cognitive effects of nicotineBiological Psychiatry, 2001
- The memory enhancing effects of a Ginkgo biloba/Panax ginseng combination in healthy middle-aged volunteersPsychopharmacology, 2000
- Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: effects of methylphenidate as measured by single photon emission computed tomographyNeuroscience Letters, 2000
- Non-stimulant treatments for ADHDEuropean Child & Adolescent Psychiatry, 2000